Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenus Regulatory News (GNS)

Share Price Information for Genus (GNS)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1,816.00
Bid: 1,812.00
Ask: 1,816.00
Change: 62.00 (3.53%)
Spread: 4.00 (0.221%)
Open: 1,740.00
High: 1,820.00
Low: 1,740.00
Prev. Close: 1,754.00
GNS Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Director/PDMR Shareholding

12 Sep 2019 14:59

RNS Number : 1736M
Genus PLC
12 September 2019
 

12 September 2019

 

Genus plc

 

Director/PDMR Shareholding

 

Genus plc (LSE: GNS) announces that on 11 September 2019, conditional nil-cost share options were granted under the Genus 2014 Performance Share Plan over ordinary shares in Genus to an Executive Director and members of the Genus Executive Leadership Team ('GELT') as listed in table A below. In addition, following Genus's compulsory deferral requirements relating to the annual bonus earned by Executive Directors and GELT for the financial year ending 30 June 2019, nil-cost share options were granted over ordinary shares under Genus's Deferred Share Bonus Plan as listed in table B below.

Details of the performance conditions that apply to the nil-cost share options can be found in the Directors' Remuneration Report of the Genus 2019 Annual Report.

The below notifications, made in accordance with the requirements of the EU Market Abuse Regulation, give further detail of the nil-cost share option awards made on 11 September 2019.

 

For further information please contact:

 

Genus:

Vaughn Walton, Deputy Company Secretary Tel: +44 (0)1256 347100

 

Table A - GELT 2014 Performance Share Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Stephen Wilson

2. Bill Christianson

3. Nate Zwald

4. Jerry Thompson

5. Dr Elena Rice

6. Angelle Rosata

7. Dan Hartley

2.

Reason for the notification

a.

Position/status

1. Group Finance Director

2. Chief Operating Officer Genus PIC

3. Chief Operating Officer Genus ABS Dairy

4. Chief Operating Officer Genus ABS Beef

5. Chief Scientific Officer & Head of R&D

6. Group Human Resources Director

7. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

 

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under the Genus plc 2014 Performance Share Plan over ordinary shares in Genus.

 

c.

Price(s) and volume(s)

Numbers 1 to 7 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

 

Volume(s)

1. 2,832p

41,666

2. 2,832p

17,682

3. 2,832p

14,892

4. 2,832p

14,806

5. 2,832p

15,450

6. 2,832p

14,163

7. 2,832p

14,512

d.

Aggregated information

·; Aggregated volume

·; Price

 

 

 

n/a

 

e.

Date of the transaction

2019-09-11

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

Table B - GELT Deferred Share Bonus Plan Options

1.

Details of the person discharging managerial responsibilities / person closely associated

a.

Name

1. Stephen Wilson

2. Bill Christianson

3. Nate Zwald

4. Jerry Thompson

5. Angelle Rosata

6. Dan Hartley

 

2.

Reason for the notification

a.

Position/status

1. Group Finance Director

2. Chief Operating Officer Genus PIC

3. Chief Operating Officer Genus ABS Dairy

4. Chief Operating Officer Genus ABS Beef

5. Group Human Resources Director

6. Group General Counsel & Company Secretary

b.

Initial notification

/Amendment

Initial notification

3.

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a.

Name

Genus plc

b.

LEI

54930022EOITNKSIGH56

4.

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a.

Description of the

Financial instrument, type of instrument

Identification code

Ordinary shares of 10p each.

 

 

GB0002074580

b.

Nature of the transaction

Award of nil-cost share options granted under Genus's Deferred Share Bonus Plan following the compulsory deferral of 25% of annual bonus in respect of bonuses earned in the financial year ending 30 June 2019. For Stephen Wilson, Dan Hartley and Bill Christianson the nil-cost share options granted under Genus's Deferred Share Bonus Plan include an additional amount of 40%, 40% and 30% of salary respectively following achievement of Company milestones during the financial year ending 30 June 2019.

 

c.

Price(s) and volume(s)

Numbers 1 to 7 in the left hand column correspond to the relevant PDMR as detailed in boxes 1a and 2a above.

 

Price(s)

 

Volume(s)

1. 2,832p

7,382

2. 2,832p

4,420

3. 2,832p

1,142

4. 2,832p

1,255

5. 2,832p

895

6. 2,832p

4,704

d.

Aggregated information

·; Aggregated volume

·; Price

 

 

 

n/a

e.

Date of the transaction

2019-09-11

f.

Place of the transaction

London Stock Exchange, Main Market (XLON)

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.
 
END
 
 
DSHUUVORKBAKAAR
Date   Source Headline
2nd Jun 20177:00 amRNSTotal Voting Rights
1st Jun 20177:05 amRNSUpdate Regarding The Milk Pension Fund
2nd May 20173:00 pmRNSTotal Voting Rights
12th Apr 20174:48 pmRNSDirector/PDMR Shareholding
3rd Apr 20172:00 pmRNSTotal Voting Rights
3rd Apr 20177:00 amRNSSUCCESSFUL LEGAL OUTCOME FOR GENUS
15th Mar 20175:15 pmRNSDirector/PDMR Shareholding
15th Mar 201712:00 pmRNSDirector Declaration
1st Mar 201710:09 amRNSDirector/PDMR Shareholding
23rd Feb 20174:20 pmRNSCorrection of Record Date
23rd Feb 20177:00 amRNSInterim Results
23rd Feb 20177:00 amRNSAcquisition and strategic partnership
7th Feb 20174:00 pmRNSHolding(s) in Company
1st Feb 20172:00 pmRNSBlock listing Interim Review
13th Dec 20163:39 pmRNSDirector/PDMR Shareholding
1st Dec 20162:00 pmRNSTotal Voting Rights
17th Nov 20162:01 pmRNSResult of AGM
17th Nov 20167:00 amRNSAGM - Trading Update
1st Nov 20164:00 pmRNSTotal Voting Rights
31st Oct 20163:47 pmRNSAnnual Report and Annual General Meeting
26th Oct 20164:00 pmRNSHolding(s) in Company
11th Oct 20164:08 pmRNSDirector/PDMR Shareholding
3rd Oct 20166:09 pmRNSBlock Listing and Additional Listing
3rd Oct 20165:57 pmRNSTotal Voting Rights
29th Sep 20165:00 pmRNSDirector/PDMR Shareholding
15th Sep 20165:00 pmRNSDirector/PDMR Shareholding
8th Sep 20165:18 pmRNSDirector/PDMR Shareholding
8th Sep 20167:00 amRNSPreliminary Results
7th Sep 20167:00 amRNSNON-EXECUTIVE DIRECTOR RETIREMENT
1st Sep 20164:17 pmRNSTotal Voting Rights
15th Aug 20167:00 amRNSFINAL JURY DECISIONS IN US LITIGATION
12th Aug 20167:00 amRNSFURTHER DECISIONS IN US LITIGATION
11th Aug 20167:00 amRNSFIRST DECISIONS IN US ANTI-TRUST LITIGATION
1st Aug 20169:20 amRNSBlock listing Interim Review
1st Aug 20169:09 amRNSTotal Voting Rights
27th Jul 20167:00 amRNSSigns exclusive licence for tech. to combat BRD
15th Jul 20167:00 amRNSAdoption of Financial Reporting Standard (FRS) 101
1st Jul 20163:10 pmRNSTotal Voting Rights
17th Jun 20164:40 pmRNSSecond Price Monitoring Extn
17th Jun 20164:35 pmRNSPrice Monitoring Extension
1st Jun 20162:00 pmRNSTotal Voting Rights
18th May 20167:00 amRNSExclusive Licence for Leading Gene Editing Tech
3rd May 20162:29 pmRNSTotal Voting Rights
13th Apr 20163:13 pmRNSDirector/PDMR Shareholding
1st Apr 20163:31 pmRNSDirector/PDMR Shareholding
9th Mar 20165:03 pmRNSDirector/PDMR Shareholding
4th Mar 20169:30 amRNSBOARD APPOINTMENT
3rd Mar 20162:00 pmRNSDirector/PDMR Shareholding
1st Mar 20165:17 pmRNSDirector/PDMR Shareholding
23rd Feb 20167:00 amRNSINTERIM RESULTS

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.